Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| genae international,ag | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this study is to compare the early clinical outcomes following non-surgical treatment with Triojection® to surgical discectomy. Early is defined as less than or equal to 6 months.
The objective of this study is to compare clinical, economic and safety outcomes between Triojection and surgical discectomy. The study will include two follow-up phases: 1) an initial follow-up period during the first 6 months after treatment and (2) a long-term follow-up lasting an additional 18 months (2 years total).
The hypothesis is that over the first six months after treatment, Triojection® will be non-inferior to discectomy with respect to the improvement in leg pain. This will be demonstrated using a non-inferiority margin of 19.4 points on the difference between baseline leg pain score and the average leg pain score recorded at 1 week, 1, 3 and 6 months.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Triojection System for ozone injection | Experimental | Triojection is a system including a single-use sterile syringe cartridge and an accessory console. The console is interfaced to a supply of medical oxygen and uses this supply to fill the syringe with oxygen. Ozone is produced by applying a high voltage to electrodes physically located within the syringe. When a concentration of 35µg/ml is reached, the cartridge is removed from the console. The sterile syringe, containing the gas, is extracted from the protective housing and the gas is administered directly to the center of the herniated disc through a spinal needle. |
|
| Surgical discectomy | Active Comparator | The surgical group will be receive a standard surgical discectomy to remove the herniated disc material. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Triojection | Device | Triojection is system intended to deliver a specific amount of ozone to a herniated disc. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Leg pain NRS | The primary outcome measure will be the amount of improvement in leg pain after treatment. This will be determined by taking the difference between the baseline score and the average of the post-treatment scores at 1 week, 1, 3 and 6 months. | Baseline, 1 week, 1, 3 and 6 months. |
| Measure | Description | Time Frame |
|---|---|---|
| Leg pain NRS | Leg pain Numerical Rating Scale (NRS) at each visit. | Baseline and 1 week, 1, 3, 6, 12, 18 and 24 months after treatment. |
| Back pain NRS | Back pain Numerical Rating Scale (NRS) at each visit |
| Measure | Description | Time Frame |
|---|---|---|
| Adverse Events | All adverse events are to be reported, per ISO 14155. | Through 24 months |
Inclusion Criteria
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Josip Buric, MD | Centro Chirurgico San Paolo, Pistoia, Italy | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University General Hospital Attikon | Athens | Haidari | 12462 | Greece | ||
| Azienda Ospedaliera Papa Giovanni XXIII |
Not provided
| ID | Term |
|---|---|
| D007405 | Intervertebral Disc Displacement |
| ID | Term |
|---|---|
| D013122 | Spinal Diseases |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D006547 | Hernia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Surgical discectomy | Procedure | Patients will receive surgery to remove the herniated disc material. |
|
| Baseline and 1 week, 1, 3, 6, 12, 18 and 24 months after treatment. |
| Functional Score measured by RMDI. | Roland Morris Disability Index. A 24 question survey asking the subject if they have difficulty with various activities of daily living. | Baseline and 1 week, 1, 3, 6, 12, 18 and 24 months after treatment. |
| Quality of Life measured by EQ-5D | EQ-5D is a validated survey asking the subject 5 multiple choice questions and to indicate their general health status on a scale of 0-100. | Baseline and 1 week, 1, 3, 6, 12, 18 and 24 months after treatment. |
| Patient Satisfaction via a survey | Brief questionnaire asking patients to rate their level of satisfaction. | Baseline and 1 week, 1, 3, 6, 12, 18 and 24 months after treatment. |
| Cost Diary | Survey asking patients to detail their medical expenses, work status, time off work etc. | Baseline and 1 week, 1, 3, 6, 12, 18 and 24 months after treatment. |
| Review of MRI images | Blinded, independent MRI review to determine reduction in disc herniation following treatment and evaluate index and adjacent levels for evidence of degeneration. | Baseline and 6 and 24 months after treatment. |
| Bergamo |
| Lombardy |
| 24127 |
| Italy |
| Ospedale Regionale di Lugano- Civico e Italiano | Lugano | 6900 | Switzerland |
| D020763 |
| Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |